Litcius/Paper detail

Biosynthesized Selenium nanoparticles as a new catalyst in the synthesis of quinazoline derivatives in pentacyclic system with docking validation as (TRPV1) inhibitor

A. M. Abdelghany, Hanan A. Soliman, Tamer K. Khatab

2021Journal of Organometallic Chemistry22 citationsDOI

Topics & Concepts

ChemistryEvodiamineRutaecarpineAldehydeCatalysisSeleniumDocking (animal)TRPV1Organic chemistryCombinatorial chemistryChromatographyBiochemistryNursingTransient receptor potential channelReceptorMedicineSynthesis and bioactivity of alkaloidsSynthesis and Biological EvaluationQuinazolinone synthesis and applications
Biosynthesized Selenium nanoparticles as a new catalyst in the synthesis of quinazoline derivatives in pentacyclic system with docking validation as (TRPV1) inhibitor | Litcius